Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a triple combination therapy for open-angle glaucoma or ocular hypertension; safety and efficacy results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Triple combination therapy (name undisclosed)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-09-10